John Thompson

John Thompson

Direttore/Membro del Consiglio presso NERVGEN PHARMA CORP.

Patrimonio netto: - $ in data 30/06/2026

59 anni
Health Technology
Consumer Services

Profilo

John Craig Thompson is currently Chief Executive Officer & Director at Cerevance, Inc. since 2022 and Independent Non-Executive Director at NervGen Pharma Corp.
since 2022.
Former roles include President, Chief Executive Officer & Director at Anthera Pharmaceuticals, Inc. from 2016 to 2018; President & Chief Executive Officer at Neurana Pharmaceuticals, Inc.; Independent Director at Esperion Therapeutics, Inc. from 2025 to 2026; Vice President-Marketing at Pfizer Inc. from 2003 to 2010; Chief Operating Officer at Tetraphase Pharmaceuticals, Inc. from 2014 to 2015; and Chief Commercial Officer at Trius Therapeutics, Inc. Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
16/05/2025 0 ( -.--% ) - $ 30/06/2026

Posizioni attive di John Thompson

SocietàPosizioneInizio
NERVGEN PHARMA CORP. Direttore/Membro del Consiglio 13/04/2022
Amministratore Delegato 01/04/2022

Precedenti posizioni note di John Thompson

SocietàPosizioneFine
ESPERION THERAPEUTICS, INC. Direttore/Membro del Consiglio 13/07/2026
ANTHERA PHARMACEUTICALS, INC. Amministratore Delegato 30/06/2018
TETRAPHASE PHARMACEUTICALS, INC. Direttore operativo 31/12/2015
PFIZER INC. Vendite & Marketing 01/01/2010
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di John Thompson

Formazione di John Thompson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. John Thompson